Morgan Stanley’s Heartbeam BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.5K Sell
58,599
-3,033
-5% -$4.84K ﹤0.01% 6288
2025
Q4
$148K Sell
61,632
-8,989
-13% -$15.4K ﹤0.01% 6043
2025
Q3
$117K Sell
70,621
-2,101
-3% -$2.7K ﹤0.01% 6084
2025
Q2
$90.9K Hold
72,722
﹤0.01% 6172
2025
Q1
$146K Buy
72,722
+66,666
+1,101% +$142K ﹤0.01% 5855
2024
Q4
$13.9K Hold
6,056
﹤0.01% 6685
2024
Q3
$14.1K Buy
6,056
+1,700
+39% +$4.11K ﹤0.01% 6616
2024
Q2
$11.2K Sell
4,356
-3,667
-46% -$8.28K ﹤0.01% 6637
2024
Q1
$17.5K Sell
8,023
-4,023
-33% -$7.59K ﹤0.01% 6528
2023
Q4
$28.3K Buy
12,046
+6,023
+100% +$8.99K ﹤0.01% 6538
2023
Q3
$12.9K Sell
6,023
-2,899
-32% -$7.37K ﹤0.01% 6638
2023
Q2
$21.5K Buy
8,922
+3,262
+58% +$7.52K ﹤0.01% 6542
2023
Q1
$12.8K Buy
5,660
+3,305
+140% +$11.6K ﹤0.01% 6795
2022
Q4
$11.5K Buy
2,355
+99
+4% +$429 ﹤0.01% 6884
2022
Q3
$9K Buy
+2,256
New +$3.59K ﹤0.01% 7094

Other funds holding BEAT

Morgan Stanley's BEAT Position: Q1 2026 in Review

Morgan Stanley reduced its Heartbeam (BEAT) stake by 4.9% in Q1 2026, selling an estimated $4.84K and leaving 58,599 shares worth $71.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6288.

Morgan Stanley first reported a position in BEAT in Q3 2022 and has held it in 15 quarters since. The position peaked at $148K in Q4 2025. 38 funds tracked by Wall St. Rank hold BEAT as of Q1 2026.

  • Morgan Stanley held 58,599 shares of Heartbeam worth $71.5K as of Q1 2026.
  • Morgan Stanley sold 3,033 Heartbeam shares in Q1 2026, an estimated $4.84K.
  • Heartbeam made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6288 holding.
  • Morgan Stanley first reported a position in Heartbeam in Q3 2022 and has held it in 15 quarters since.
  • Morgan Stanley's Heartbeam position peaked at $148K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Heartbeam as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.